|
Maximus, Inc. (MMS): ANSOFF Matrix Analysis [Jan-2025 Mise à jour] |
Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
Pré-Construits Pour Une Utilisation Rapide Et Efficace
Compatible MAC/PC, entièrement débloqué
Aucune Expertise N'Est Requise; Facile À Suivre
Maximus, Inc. (MMS) Bundle
Dans le paysage dynamique des services gouvernementaux et des solutions de soins de santé, Maximus, Inc. (MMS) apparaît comme une puissance stratégique, traduisant méticuleusement sa trajectoire de croissance grâce à une matrice ANSOff complète. En mélangeant de manière transparente des technologies innovantes, de l'expansion ciblée du marché et des modèles de services transformateurs, la société est prête à redéfinir l'engagement du secteur public et l'efficacité opérationnelle dans plusieurs domaines - des plates-formes numériques aux solutions alimentées par l'IA qui promettent pour révolutionner la façon dont les gouvernements et les organisations fournissent des humains critiques humains et alimentés par l'IA qui promettent pour révolutionner la façon dont les gouvernements et les organisations fournissent un humain critique humain et humain critique services.
Maximus, Inc. (MMS) - Matrice Ansoff: pénétration du marché
Développez les contrats de services gouvernementaux sur les marchés des États et fédéraux existants
Maximus, Inc. a déclaré 4,2 milliards de dollars de revenus totaux pour l'exercice 2022, les services gouvernementaux représentant 68% de la valeur totale du contrat. Le portefeuille de contrats fédéraux actuel comprend 47 contrats actifs dans 12 agences fédérales.
| Type de contrat | Valeur annuelle | Durée du contrat |
|---|---|---|
| Services de santé fédéraux | 1,3 milliard de dollars | 5 ans |
| État soutien de Medicaid | 892 millions de dollars | 3-4 ans |
Augmenter la vente croisée des solutions de soins de santé et de services sociaux
Le taux actuel de rétention des clients s'élève à 92%. La clientèle existante comprend 36 gouvernements des États et 15 agences fédérales.
- Taux de vente croisée Solutions de soins de santé: 27%
- Taux de vente croisée Solutions des services humains: 22%
- Revenus supplémentaires potentiels de la vente croisée: 215 millions de dollars
Mettre en œuvre des campagnes de marketing ciblées
Budget marketing pour 2022: 42 millions de dollars, représentant 1,8% du total des revenus.
| Canal de marketing | Allocation | ROI attendu |
|---|---|---|
| Marketing numérique | 18,5 millions de dollars | 3.2x |
| Conférences de l'industrie | 7,3 millions de dollars | 2.7x |
Améliorer les programmes de rétention de la clientèle
Score de satisfaction client actuel: 88/100. Taux de renouvellement du contrat moyen: 94%.
- Investissement dans le support client: 37 millions de dollars par an
- Temps de réponse moyen: 2,4 heures
- Taille de l'équipe du support client: 423 professionnels
Optimiser les stratégies de tarification
L'analyse des prix compétitives montre que Maximus maintient un avantage de prix de 12% par rapport aux concurrents de l'industrie.
| Segment de service | Stratégie de tarification | Marge |
|---|---|---|
| Services de santé | Prix basés sur la valeur | 22% |
| Services sociaux | Prix basés sur les performances | 19% |
Maximus, Inc. (MMS) - Matrice Ansoff: développement du marché
Expansion internationale dans les pays anglophones
Maximus, Inc. a généré 4,2 milliards de dollars de revenus en 2022, avec des marchés internationaux représentant 12,3% des revenus totaux. La présence internationale actuelle comprend les contrats de service gouvernemental du Canada et du Royaume-Uni.
| Pays | Contrats du gouvernement | Valeur du contrat |
|---|---|---|
| Canada | Services à l'emploi | 187 millions de dollars |
| Royaume-Uni | Santé et services sociaux | 213 millions de dollars |
Expansion géographique aux États-Unis
Maximus a étendu les services à 37 États en 2022, ciblant les marchés des soins de santé et des services sociaux.
- Gestion du programme Medicaid dans 24 États
- Services de soutien à Medicare dans 19 États
- Gestion du système d'assurance chômage dans 12 États
Partenariats stratégiques avec les agences gouvernementales
Maximus a établi 14 nouveaux partenariats d'agence gouvernementale en 2022, augmentant le portefeuille total de partenariats à 68 entités gouvernementales.
| Type de partenariat | Nombre de nouveaux partenariats | Valeur annuelle totale |
|---|---|---|
| Niveau d'État | 9 | 312 millions de dollars |
| Niveau fédéral | 5 | 247 millions de dollars |
Extension de plate-forme numérique
Les plates-formes de services numériques ont augmenté de 37% en 2022, atteignant 42 plates-formes de services gouvernementaux numériques.
- Plateformes de service de télésanté: 18
- Systèmes de gestion des avantages en ligne: 24
Adaptation réglementaire régionale
Les investissements d'adaptation de conformité ont totalisé 56 millions de dollars en 2022, couvrant les exigences réglementaires dans 42 juridictions.
| Zone de réglementation | Investissements d'adaptation | Couverture de conformité |
|---|---|---|
| Règlement sur les soins de santé | 34 millions de dollars | 37 juridictions |
| Règlements sur les services sociaux | 22 millions de dollars | 29 juridictions |
Maximus, Inc. (MMS) - Matrice Ansoff: développement de produits
Développer des plateformes numériques avancées pour la gestion des avantages sociaux et les services de santé
Maximus, Inc. a investi 127,6 millions de dollars dans le développement de plateformes numériques au cours de l'exercice 2022. La société a obtenu 37 nouveaux contrats de technologie gouvernementaux d'une valeur de 456 millions de dollars au cours de cette période.
| Investissement de plate-forme numérique | Valeur |
|---|---|
| Dépenses totales de R&D | 127,6 millions de dollars |
| Nouveaux contrats gouvernementaux | 37 contrats |
| Valeur du contrat | 456 millions de dollars |
Créer des solutions alimentées par l'IA pour une prestation de services sociaux plus efficace
Maximus a développé 12 solutions axées sur l'IA en 2022, ciblant les soins de santé et l'optimisation des services sociaux.
- Déploiement de la solution d'IA a augmenté l'efficacité opérationnelle de 28%
- Réduction du temps de traitement pour les applications de prestations de 42%
- Des algorithmes d'apprentissage automatique implémentés dans 6 systèmes de soins de santé au niveau de l'État
Investissez dans des technologies de télésanté et de gestion des services à distance
Les investissements en télésanté ont atteint 93,4 millions de dollars en 2022, soutenant 22 plateformes de technologie de santé de l'État.
| Catégorie d'investissement de télésanté | Montant |
|---|---|
| Investissement total de télésanté | 93,4 millions de dollars |
| Plateformes d'État prises en charge | 22 plateformes |
Développer les services de conseil et de mise en œuvre de la technologie pour les agences gouvernementales
Maximus a étendu les services de conseil à 45 nouvelles agences gouvernementales en 2022, générant 287,3 millions de dollars de revenus supplémentaires.
- NOUVELLES PARTENAIS AGENCES: 45
- Revenus de consultation: 287,3 millions de dollars
- Valeur du contrat moyen: 6,38 millions de dollars
Concevoir des outils d'innovation d'analyse de données pour l'optimisation des performances du secteur public
Le développement des outils d'analyse de données a consommé 64,2 millions de dollars de dépenses en R&D, ce qui a entraîné 9 nouvelles plateformes d'optimisation des performances.
| Investissement d'analyse des données | Valeur |
|---|---|
| Dépenses de R&D | 64,2 millions de dollars |
| Nouvelles plateformes de performance | 9 plateformes |
Maximus, Inc. (MMS) - Matrice Ansoff: diversification
Explorez les marchés émergents dans la gestion des infrastructures sociales compatibles avec la technologie
Maximus a généré 4,2 milliards de dollars de revenus pour l'exercice 2022, les services gouvernementaux représentant 87% des revenus totaux. Le segment de gestion des infrastructures technologiques de la société a augmenté de 12,3% en glissement annuel.
| Segment de marché | Croissance projetée | Allocation des investissements |
|---|---|---|
| Technologie des infrastructures sociales | 15.7% | 62,5 millions de dollars |
| Services gouvernementaux numériques | 18.2% | 78,3 millions de dollars |
Développer des services de conseil pour les organisations de soins de santé et de services sociaux du secteur privé
Maximus a déclaré 1,1 milliard de dollars de revenus de conseil en soins de santé pour 2022, ce qui représente une augmentation de 9,6% par rapport à l'année précédente.
- Base de clients de conseil en santé élargie par 22 nouvelles organisations
- La valeur moyenne du contrat est passée de 3,2 millions de dollars à 4,7 millions de dollars
- Taille du marché projeté pour le conseil en santé: 87,3 milliards de dollars d'ici 2025
Investissez dans des technologies émergentes comme la blockchain pour la prestation de services gouvernementaux sécurisés
| Investissement technologique | Allocation | ROI attendu |
|---|---|---|
| Blockchain Infrastructure | 45,6 millions de dollars | 17.3% |
| Améliorations de la cybersécurité | 38,2 millions de dollars | 15.9% |
Créer des solutions de formation et de développement de la main-d'œuvre innovantes
Le segment du développement de la main-d'œuvre a généré 276 millions de dollars de revenus, avec un taux de croissance de 14,5% en 2022.
- Formé 127 500 personnes dans des secteurs public et privé
- Valeur du programme de formation moyen: 42 000 $ par cohorte
- Taux de satisfaction du client: 94,3%
Enquêter sur les acquisitions potentielles dans la technologie complémentaire et les domaines de service
| Cible d'acquisition potentielle | Valeur estimée | Ajustement stratégique |
|---|---|---|
| Plate-forme de santé numérique | 215 millions de dollars | Forte compatibilité |
| Société des services informatiques du gouvernement | 340 millions de dollars | Synergie forte |
Maximus, Inc. (MMS) - Ansoff Matrix: Market Penetration
You're looking at how Maximus, Inc. (MMS) can deepen its hold in current markets, which is the essence of Market Penetration. This isn't about new customers in new places; it's about getting more business from the customers you already serve, like the U.S. Federal government.
For the full fiscal year 2025, Maximus reported total revenue of $5.43 billion, which was a 2.4% increase year-over-year, with organic growth coming in at 3.9%. This strategy is clearly working best in the Federal space. The U.S. Federal Services segment was the engine, expanding by 12.1% to generate $3.07 billion in revenue for FY2025. That segment's operating margin hit 15.3%, showing that deeper penetration there drives better profitability.
Consider the recompete success for the VA Medical Disability Examination (MDE) services. Veterans Evaluation Services (VES), a Maximus Company, secured re-awarded contracts for domestic Regions 1 through 4, effective January 1, 2025. Each of those four regional contracts includes a one-year base period plus a single option year. This win ensures uninterrupted service and the cumulative value of the award more than covers current and anticipated production volumes. You also successfully opposed early recompete attempts for CMS Contact Center Operations, securing successor contracts there, which is a direct win-rate success in existing federal domains.
Here's a quick look at how the segments performed in FY2025, showing where the penetration focus is yielding results:
| Segment | FY2025 Revenue (USD) | YoY Revenue Change | FY2025 Operating Margin |
|---|---|---|---|
| U.S. Federal Services | $3.07 billion | +12.1% | 15.3% |
| U.S. Services | $1.76 billion | -7.7% | N/A |
| Outside the U.S. | $599.9 million | -8.7% | N/A |
| Total Company | $5.43 billion | +2.4% | 9.7% |
The push to cross-sell clinical assessment services into existing Federal civilian agency contracts is supported by the segment's growth, which was driven primarily by elevated volumes on clinical programs. While we don't have a specific cross-sell dollar amount, the 12.1% revenue increase in that segment is the outcome of successfully expanding service lines within that existing customer base.
For state-level Medicaid programs, the numbers show a normalization rather than immediate growth in engagement volumes. The U.S. Services Segment revenue fell by 7.7% to $1.76 billion for the full year. This decrease is attributed to the prior year period containing excess volumes from Medicaid-related activities, like the unwinding exercise that drove extra redeterminations. The action here is to monitor state-level contingency plans, as changes requiring consumer engagement, such as eligibility verification, are what typically increase your BPO volumes.
Operational efficiency is showing tangible results. For the full fiscal year 2025, the adjusted EBITDA margin was 12.9%, an expansion from 11.6% in the prior year. This is a clear step toward your goal. To show the potential for further expansion, look at the third quarter of fiscal year 2025, where the adjusted EBITDA margin reached 14.7%. Driving higher volumes in the Federal segment, combined with technology and cost initiatives, is what delivered that year-over-year improvement.
To keep this momentum going, you need to focus on:
- Secure successor contracts for all expiring Federal clinical programs.
- Integrate technology modernization across all existing MDE service regions.
- Translate Q3's 14.7% adjusted EBITDA margin into a sustained full-year metric.
- Identify specific civilian agencies for targeted clinical assessment service proposals.
Maximus, Inc. (MMS) - Ansoff Matrix: Market Development
You're looking at how Maximus, Inc. (MMS) plans to take its existing, proven services and push them into new customer bases or geographies. This is Market Development, and for Maximus, Inc., it's heavily weighted toward deepening its relationship with the U.S. Federal government while eyeing international returns.
The sheer scale of future opportunity is clear in the numbers. As of September 30, 2025, the total sales pipeline for Maximus, Inc. stood at an impressive $51.3 billion. That's a significant jump from the $44.7 billion reported in the prior quarter. What this estimate hides is that not all of that is immediately actionable; still, 64% of that total pipeline represents new work opportunities. You see a clear geographic and sector focus here, as 66% of that $51.3 billion is attributable to the U.S. Federal Services segment.
Expand the U.S. Federal Services footprint into new defense and intelligence sectors.
Maximus, Inc. is actively converting pipeline into tangible defense contracts, which often carry higher margins. For instance, the company secured a new Joint Cyber Command & Control Readiness contract with the U.S. Air Force, valued up to $86 million. This followed a July 2025 award from the Air Force's Cryptologic and Cyber Systems Division for cybersecurity and cloud services, valued at $77 million. This segment was the clear growth engine for fiscal year 2025, expanding revenue by 12.1%, reaching $3.07 billion.
Target new state and local government markets with existing health and human services platforms.
While the Federal segment is surging, the U.S. Services segment, which includes state and local work, saw revenue decrease by 7.7% to $1.76 billion in fiscal year 2025. A big part of that was the normalization after the heavy volume from Medicaid redeterminations unwinding, which impacted the prior year. The strategy here is to pivot existing health and human services platforms to new state-level needs, like the recent contract award for the Massachusetts Health Connector. The company is positioning its platforms to capture demand driven by new state policy requirements.
Re-enter select international markets with high-margin, tech-enabled services after divestitures.
Maximus, Inc. has been streamlining its international presence, having completed divestitures of employment services businesses, including operations in Australia and South Korea. The focus for re-entry or expansion in the remaining Outside the U.S. (OUS) operations is clearly on profitability. For fiscal year 2026, the company is projecting an operating margin for the OUS segment in the range of 3-5%. This suggests a highly selective approach, prioritizing tech-enabled services that can deliver better margins than prior international footprints.
Focus the $51.3 billion sales pipeline on new geographic regions within the U.S.
The pipeline focus is overwhelmingly federal, but the strategy is about expanding the type of work within the U.S. The $51.3 billion pipeline is heavily skewed toward new federal opportunities, which is where the company sees the most immediate, high-value growth. This is about developing new relationships within the defense and intelligence agencies, rather than just chasing existing state-level contracts that are normalizing post-pandemic. The company's total revenue for fiscal year 2025 was $5.43 billion.
Introduce Veterans Affairs clinical services model to other national veteran programs globally.
Maximus, Inc. solidified its clinical assessment capability by acquiring Veterans Evaluation Services, Inc. (VES) for $1.4 billion back in 2021. VES is a premier provider of Medical Disability Examinations (MDEs) for the U.S. Department of Veterans Affairs (the VA). The model involves using a global network of over 8,000 providers across over 3,100 exam locations, including mobile fleets, to deliver timely, high-quality evaluations. The Market Development move here is leveraging the established success and infrastructure of the VA clinical model-which is a core part of the U.S. Federal Services segment-to pursue similar health and disability assessment contracts with other national veteran programs outside the U.S. The company is already a leading provider of government services worldwide.
Here's a quick look at the segment performance driving the strategy:
| Metric | FY 2025 Actual Value | Source Segment |
|---|---|---|
| Total Revenue | $5.43 billion | Total Company |
| U.S. Federal Services Revenue | $3.07 billion | U.S. Federal Services |
| U.S. Federal Services Revenue Growth | 12.1% | U.S. Federal Services |
| U.S. Services Revenue | $1.76 billion | U.S. Services |
| U.S. Services Revenue Change | -7.7% | U.S. Services |
| Total Sales Pipeline | $51.3 billion | Total Company |
The company's focus on tech-enabled services is evident in its AI deployments, with 30 AI deployments noted, positioning them for higher-value work. Finance: draft the FY2026 capital allocation plan prioritizing defense M&A by next Wednesday.
Maximus, Inc. (MMS) - Ansoff Matrix: Product Development
You're looking at how Maximus, Inc. (MMS) is building new offerings-that's the Product Development quadrant of the Ansoff Matrix. It's about taking what you know and making something new for your existing government clients. Honestly, the numbers from fiscal year 2025 show this isn't just theory; it's happening now.
Integrate advanced Artificial Intelligence (AI) and machine learning into contact center operations.
Maximus, Inc. is definitely pushing technology into service delivery. They established an 'AI and data accelerator' during the fiscal year. Management noted pursuing the implementation of technologies like artificial intelligence and machine learning to achieve operational efficiency. We see evidence of this with 30 AI deployments mentioned in their recent performance review. This focus on smart technology helped earn Maximus a spot on the 2025 Fortune America's Most Innovative Companies list.
Roll out the new Total Experience Management platform across all major U.S. Services contracts.
The Total Experience Management (TXM) platform, which was updated and powered by Amazon Web Services, is a key product here. It integrates AI-assisted interactions, using tools like Amazon Bedrock, Amazon Lex, and Amazon Textract for intelligent document processing. When agencies use TXM, they've seen concrete results, like $26 million in reduced onboarding costs and a 27 percent improvement in quality scores within the first six weeks. Plus, they reported a 198% reduction in employee turnover from early adopters. This platform also integrates with Salesforce's Agentforce to augment teams with autonomous AI agents.
Develop new cybersecurity and cloud modernization offerings for federal IT systems.
This is a clear move into new product territory within the existing federal market. A perfect example of this product development in action was securing an $77 million contract with the U.S. Air Force specifically for cybersecurity and cloud services in 2025. This shows they are actively packaging and selling these modernized capabilities as distinct offerings.
Create specialized clinical assessment tools for emerging public health mandates.
The U.S. Federal Services segment, which brought in $3.07 billion in revenue for FY 2025, is a major beneficiary of these new tools. A proprietary AI-powered system, developed through Veterans Evaluation Services, transformed manual claims reviews into a fast, scalable digital process. This new tool is now improving outcomes at the Centers for Medicare & Medicaid Services (CMS). This is taking their clinical expertise and wrapping it in a new, more efficient technological product.
Invest a portion of the $366.2 million free cash flow into proprietary software development.
The financial muscle for this development comes from strong cash generation. Maximus, Inc. generated $366.2 million in free cash flow for the full fiscal year 2025. That cash flow, alongside an adjusted diluted EPS of $7.36 for the year, provides the capital base to fund the creation of these proprietary assets. Here's a quick look at the financial context supporting these investments:
| Metric | FY 2025 Actual Amount | Context |
| Total Revenue | $5.43 billion | Full year reported revenue |
| Free Cash Flow (FCF) | $366.2 million | Full year cash generation for investment |
| Adjusted Diluted EPS | $7.36 | Full year profitability metric |
| U.S. Federal Services Revenue | $3.07 billion | Segment driving organic growth |
| TXM Onboarding Cost Reduction | $26 million | Reported savings for early adopters |
These product developments are designed to drive margin expansion, which management is clearly achieving, as seen by the adjusted EBITDA margin expanding to 12.9% in FY 2025.
You should review the capital allocation plan against the projected FY 2026 FCF guidance of $450 million to $500 million to see how much more is earmarked for these proprietary software efforts next year. Finance: draft 13-week cash view by Friday.
Maximus, Inc. (MMS) - Ansoff Matrix: Diversification
You're looking at where Maximus, Inc. can push beyond its core government service contracts, which is the heart of diversification strategy.
Commercializing government-grade AI/BPM tools for highly regulated private sectors, like finance, aligns with the U.S. Federal Services Segment revenue growth of 12.1% in fiscal year 2025, reaching $3.07 billion. This suggests a proven technology base ready for transfer.
To accelerate momentum from the $86 million Joint Cyber Command and Control Readiness contract with the Air Force, an acquisition in specialized defense technology would be a clear move. This follows a previous $77 million contract win with the Air Force Life Cycle Management Center in July 2025.
Establishing a new international segment focused purely on high-tech consulting for foreign governments would be a pivot from the current structure. The Outside the U.S. Segment revenue for fiscal year 2025 was $599.9 million, a decrease of 8.7% year-over-year, showing room for a new, high-margin focus area to stabilize or grow that revenue base.
Partnering with a private healthcare system to manage complex eligibility and enrollment processes taps into the U.S. Services Segment, which supports programs like Medicaid and the Children's Health Insurance Program (CHIP). This segment generated $1.76 billion in revenue for fiscal year 2025, despite a 7.7% decline from the prior year.
Targeting the 64% of the pipeline representing new work with entirely new service lines is a direct call for diversification. The total sales pipeline as of the latest report stands at $51.3 billion in opportunities. This 64% portion represents a potential $32.832 billion in future, non-core work, assuming the pipeline composition holds steady.
Here's a quick look at the overall financial picture from fiscal year 2025:
| Metric | Value (FY 2025) | Comparison/Context |
|---|---|---|
| Total Revenue | $5.43 billion | 2.4% increase year-over-year |
| Adjusted Diluted EPS | $7.36 | 20% increase from FY 2024 |
| Adjusted EBITDA Margin | 12.9% | Up from 11.6% in the prior year |
| Free Cash Flow | $366 million | Compared to $401 million in the prior fiscal year quarter |
| Shares Repurchased | Approximately 5.8 million shares | Totaling about $456.6 million |
The operational results defintely show where the current strength lies, but the pipeline suggests where the next growth vectors must be:
- U.S. Federal Services Segment Operating Margin: 15.3%
- U.S. Services Segment Operating Margin: 9.7%
- Outside the U.S. Segment Operating Margin: 3.7%
- Total Sales Pipeline: $51.3 billion
- New Work Opportunities in Pipeline: 64%
- Debt-to-EBITDA Ratio (as of Sept 30, 2025): 1.5x
Finance: draft 13-week cash view by Friday.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.